Xilio Therapeutics, Inc. (XLO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Xilio Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -21.38x | -0.88x | -0.20x | -0.84x | -1.18x | -0.15x |
| P/B Ratio | 21.23x | 2.90x | 0.41x | 0.70x | 0.48x | -1.59x |
| P/S Ratio | 17.11x | 8.06x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 96.5% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -95.9% | -954.9% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -80.1% | -918.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -92.4% | -914.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.58x | 2.21x | 3.02x | 5.89x | 15.85x | 0.93x |
| Quick Ratio | 2.58x | 2.21x | 3.02x | 5.89x | 15.85x | 0.93x |
| Leverage | ||||||
| Debt/Equity | 0.20x | 0.46x | 0.31x | 0.19x | 0.11x | -4.14x |
YoY = year-over-year change. Source: FMP..